
Gene Therapy Slows Huntington’s Progression 75% — Including Dementia
For the first time, a one-time treatment has shown the ability to slow Huntington’s decline — including dementia symptoms — over three years.

For the first time, a one-time treatment has shown the ability to slow Huntington’s decline — including dementia symptoms — over three years.

J147 is a derivative of curry’s turmeric spice. It beat the Alzheimer’s drug Aricept (generic: donepezil) on several memory tests. The Salk Institute says it may benefit Parkinson’s, Huntington’s & vascular dementia.

Triheptanoin is available as a supplement or by prescription. A series of studies suggest it improves brain energy metabolism for people with Huntington’s disease. Learn how.

Researchers have been able to mobilize the brain’s native stem cells to replenish a type of neuron lost in Huntington’s disease. Learn how they improved health and extended life in the lab.

Geneticists have discovered a promising direction in Huntington’s treatment. In the lab, glutathione peroxidase improved Huntington’s disease. Drugs mimicking this activity are already approved for

DRUG NEWS: Genentech will showcase the breadth and promise of their Neuroscience Portfolio at the 2019 American Academy of Neurology Annual Meeting. It includes new

As research continues, cures for dementias such as Huntington’s are within our grasp. Your support can help make the next discovery possible.

Researchers discovered how genetic mutations in Huntington’s disease kill brain cells. Learn why this discovery may be relevant to other types of dementia, as well.

New research shows that the Alzheimer’s drug memantine (Namenda™) may treat Huntington’s dementia. It seems to improve motor learning and coordination, as well as keep cells alive. It appears to work in a way that could also benefit dementia in traumatic brain injury and some forms of stroke. Can memantine offer a multi-type dementia breakthrough?

Three major GLP-1 trials came out in late 2025. One weight-loss drug slowed early Alzheimer’s decline, while two others failed. Surprisingly, this mixed pattern may point the way toward a promising new treatment direction.

New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight years—offering families precious time and renewed hope.

Strengthening social connections may offer a surprising boost to long-term brain health.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


